Form4insider filings, from the source

SEC Form 4 · accession 0001203311-18-000051

SEATTLE GENETICS INC /WA · SGEN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Darren S Cline
Officer — EVP, Commercial
Period of report
Jun 12, 2018
Accepted (ET)
Jun 14, 2018 · 6:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJun 12, 2018M892$16.41A72,723D
Common StockJun 12, 2018S892$69.00D71,831D
Common StockJun 12, 2018M268$15.46A72,099D
Common StockJun 12, 2018S268$69.00D71,831D
Common StockJun 12, 2018M926$26.10A72,757D
Common StockJun 12, 2018S926$69.00D71,831D
Common StockJun 12, 2018M8,000$31.37A79,831D
Common StockJun 12, 2018S8,000$69.00D71,831D
Common StockJun 12, 2018S718$68.90D71,113D
Common StockJun 12, 2018S1,250$69.027D69,863D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Non-Qualified Stock Option (right to buy)F1$15.46Jun 12, 2018M268D—Aug 24, 2021Common Stock2680D
Non-Qualified Stock Option (right to buy)F2$16.41Jun 12, 2018M892D—Oct 29, 2020Common Stock8920D
Non-Qualified Stock Option (right to buy)F3$26.10Jun 12, 2018M926D—Aug 20, 2022Common Stock9260D
Non-Qualified Stock Option (right to buy)F4$31.37Jun 12, 2018M8,000D—Feb 3, 2025Common Stock8,0001,583D

Explanation of responses